Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial

IMPORTANCE: Stereotactic body radiotherapy (SBRT) for oligometastases is hypothesized to improve survival and is increasingly used. Little evidence supports its safe use to treat patients with multiple metastases. OBJECTIVE: To establish safety of SBRT dose schedules in patients with 3 to 4 metastas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Oncol
Main Authors: Chmura, Steve, Winter, Kathryn A., Robinson, Clifford, Pisansky, Thomas M., Borges, Virginia, Al-Hallaq, Hania, Matuszak, Martha, Park, Sean S., Yi, Sun, Hasan, Yasmin, Bazan, Jose, Wong, Philip, Yoon, Harold A., Horton, Janet, Gan, Gregory, Milano, Michael T., Sigurdson, Elin Ruth, Moughan, Jennifer, Salama, Joseph K., White, Julia
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063134/
https://ncbi.nlm.nih.gov/pubmed/33885704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.0687
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki